EENT · PANCE / PANRE

Traumatic Hyphema

Blood in the anterior chamber after blunt trauma — risk of rebleed (days 2-5), elevated IOP, and corneal staining; head up, eye shield, sickle screen.

Also known as: hyphema, traumatic hyphema, microhyphema, 8-ball hyphema

Overview

Accumulation of red blood cells in the anterior chamber of the eye, most commonly following blunt or penetrating ocular trauma. Microhyphema refers to circulating red blood cells visible only on slit-lamp examination, without a visible layered blood level.

Epidemiology

Estimated incidence 12-20 per 100,000 per year. Predominantly affects young men; sports, assault, and projectile injuries (paintballs, fireworks, BB guns) are the most common mechanisms. Children are also at risk from blunt trauma. Spontaneous (nontraumatic) hyphema is uncommon and suggests neovascular disease, intraocular tumor (juvenile xanthogranuloma, retinoblastoma), iris vascular anomaly, or bleeding diathesis.

Try two board-style Traumatic Hyphema questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1EENTEasy
A 19-year-old man presents to the emergency department after being struck in the right eye by a paintball during a game 1 hour ago. He reports pain, blurred vision, and light sensitivity in that eye. On examination, visual acuity is reduced to 20/80 on the right. Slit-lamp examination of the upright patient shows a layer of red blood cells filling less than one-third of the anterior chamber, and intraocular pressure is 28 mm Hg. The cornea is clear, the pupil is round and reactive, and there is no visible laceration or vitreous prolapse. Which of the following is the most likely diagnosis?
  • AOpen globe injury
  • BTraumatic hyphema
  • CAnterior uveitis
  • DEndophthalmitis
Reveal answer & full explanation
Correct answer: B — Traumatic hyphema
  • AOpen globe injury
  • BTraumatic hyphema
  • CAnterior uveitis
  • DEndophthalmitis

Why Traumatic hyphema is correct

  • Blunt ocular trauma (here, a paintball) tears the iris root and ciliary body and ruptures the major arterial circle of the iris, producing layered red blood cells in the anterior chamber.
  • The classic picture is gross blood layering inferiorly in the upright patient (Grade I = less than 1/3 of the chamber), reduced visual acuity, and elevated intraocular pressure — exactly this vignette.
  • Management is supportive: rigid eye shield (not a pressure patch), head elevation to 30-45 degrees, topical cycloplegic and corticosteroid, avoidance of aspirin/NSAIDs, and daily ophthalmology follow-up for 5-7 days because rebleed at days 2-5 worsens outcomes. Screen for sickle cell disease/trait in at-risk patients.

Why the others are wrong

  • Anterior uveitis — inflammation producing white blood cells and flare in the anterior chamber, with pain and photophobia, but it does not produce a layered level of red blood cells and is usually non-traumatic.
  • Endophthalmitis — intraocular infection causing pain and vision loss with a hypopyon (a layer of white inflammatory cells, not red blood); it follows recent surgery or penetrating injury, not blunt trauma with a clear cornea.
  • Open globe injury — full-thickness scleral/corneal rupture showing a distorted/peaked pupil, shallow chamber, or vitreous prolapse; IOP measurement is contraindicated. This eye has a round pupil, no laceration, and a measurable normal-to-mildly-elevated pressure.
Question 2EENTMedium
A 19-year-old man presents to the emergency department after being struck in the right eye by a paintball during a game earlier that day. He reports pain and blurred vision. On slit-lamp examination, blood is layered across the lower one-third of the anterior chamber, and intraocular pressure is 18 mm Hg. A rigid eye shield is placed, the head of the bed is elevated, and he is started on a topical cycloplegic and corticosteroid with daily ophthalmology follow-up. Over the next several days, which of the following complications is this patient most likely to develop?
  • ACorneal stromal blood staining
  • BAnterior chamber rebleeding
  • CLate angle-recession glaucoma
  • DTractional retinal detachment
Reveal answer & full explanation
Correct answer: B — Anterior chamber rebleeding
  • ACorneal stromal blood staining
  • BAnterior chamber rebleeding
  • CLate angle-recession glaucoma
  • DTractional retinal detachment

Why Anterior chamber rebleeding is correct

  • Rebleeding is the single most consequential early complication of traumatic hyphema, classically occurring on days 2-5 as the initial clot retracts and lyses.
  • A secondary hemorrhage is typically larger than the original bleed and sharply increases the risk of every downstream complication such as acute IOP spikes, corneal staining, and optic atrophy, which is why head elevation, a rigid shield, avoidance of aspirin and NSAIDs, and daily exams during the first week are the foundation of management.

Why the others are wrong

  • Corneal stromal blood staining is a real hyphema complication, but it follows prolonged or recurrent hemorrhage with sustained elevated IOP, not the first several days of a small grade I bleed; it is downstream of rebleeding rather than the most likely early event.
  • Late angle-recession glaucoma is a genuine long-term sequela of blunt trauma that develops months to years later, which is why gonioscopy is deferred 3-4 weeks and lifelong glaucoma surveillance is advised; it is not expected over the next several days.
  • Tractional retinal detachment is characteristic of proliferative diabetic retinopathy and other neovascular or fibrotic vitreoretinal disease, not of an acute traumatic hyphema; this is a wrong-mechanism distractor.
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Traumatic Hyphema outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Blunt ocular trauma (sports, fist, projectile)
  • Penetrating ocular trauma
  • Anticoagulant or antiplatelet therapy
  • Bleeding disorders (hemophilia, von Willebrand disease)
  • Sickle cell disease or trait — markedly worsens outcome
  • Recent intraocular surgery
  • Iris neovascularization (diabetic retinopathy, central retinal vein occlusion)
  • Intraocular tumors

Pathophysiology

Blunt trauma transmits a shockwave that abruptly equatorially expands the globe, tearing the iris root, ciliary body, or both (anterior segment angle structures), with associated rupture of the major arterial circle of the iris and/or ciliary body. Blood accumulates in the anterior chamber. Clot retraction and lysis at days 2-5 carry the highest risk of rebleed. Free hemoglobin in the AC and outflow obstruction by red cells and clot can elevate intraocular pressure. Prolonged or recurrent hemorrhage causes corneal endothelial damage and bloodstaining of the cornea.

Clinical presentation

Symptoms

  • Pain, blurred vision, and history of recent blunt or penetrating eye trauma
  • Photophobia
  • Headache, nausea, or vomiting may indicate elevated intraocular pressure
  • Diplopia or restricted motility suggests orbital fracture or muscle entrapment

Signs / physical exam

  • Grossly visible blood layering in the anterior chamber when upright
  • Grade 0: microhyphema only (no layer); Grade I: less than 1/3 of AC; Grade II: 1/3 to 1/2 of AC; Grade III: greater than 1/2 but not total; Grade IV (8-ball or total): entire AC filled
  • Reduced visual acuity
  • Elevated intraocular pressure (early or delayed)
  • Sluggish pupil or sphincter tears
  • Iridodialysis, cyclodialysis, lens dislocation, retinal pathology on dilated exam (when safe)
  • Corneal blood staining in prolonged or repeat hemorrhage

Classic findings

Layered blood in the anterior chamber after blunt trauma, with elevated IOP and reduced acuity.

Differential diagnosis

  • Microhyphema (without layered blood) — Cells in AC on slit lamp only; same management principles
  • Anterior uveitis — Cells and flare in AC without red cells; pain, photophobia, often non-traumatic
  • Spontaneous hyphema from neovascular disease — No trauma history; diabetic retinopathy, vein occlusion, or rubeosis on dilated fundus exam
  • Endophthalmitis — Pain, vision loss, hypopyon (white not red), recent surgery or penetrating injury
  • Open globe injury — Distorted pupil, shallow chamber, vitreous prolapse, visible laceration; do NOT measure IOP; protective shield
  • Traumatic iritis — Cells and flare without significant red cells; ciliary spasm

Diagnostic workup

Diagnostic criteria

Clinical diagnosis by slit-lamp examination demonstrating red blood cells in the anterior chamber after trauma.

Labs

  • Sickle cell screen (Sickledex) and hemoglobin electrophoresis if African, Caribbean, Mediterranean, Middle Eastern, or South Asian ancestry — sickling in the AC even with trait can elevate IOP dangerously and limit medication options
  • CBC, PT/INR if anticoagulated or bleeding diathesis suspected
  • Type and screen if surgery anticipated

Imaging

  • Slit-lamp examination and measurement of IOP (gentle, after ruling out open globe)
  • Dilated fundoscopy and B-scan ultrasound if media opacity prevents posterior segment view (and globe is intact) to evaluate for vitreous hemorrhage, retinal detachment, or intraocular foreign body
  • CT orbits without contrast if orbital fracture, retained foreign body, or open globe is suspected — never MRI if metallic foreign body possible
  • Gonioscopy is DEFERRED for at least 3-4 weeks to allow stabilization, then performed to assess for angle recession (predisposes to late glaucoma)

Diagnostic algorithm

flowchart TD
  A[Blunt eye trauma<br/>+ blood in AC] --> B{Open globe<br/>features?}
  B -->|Yes| C[Shield only<br/>NPO<br/>CT orbit<br/>emergent ophtho]
  B -->|No| D[Slit lamp + IOP<br/>+ acuity<br/>+ sickle screen]
  D --> E[Shield<br/>head up 30-45°<br/>cycloplegic + topical steroid<br/>no NSAIDs/ASA]
  E --> F[Daily ophthalmology<br/>x 5-7 days]
  F --> G{Rebleed<br/>or IOP elevation?}
  G -->|No| H[Outpatient course<br/>gonioscopy at 3-4 wk]
  G -->|Yes| I[Add IOP medications<br/>± antifibrinolytics<br/>consider admission]
  I --> J{Corneal staining<br/>or refractory IOP?}
  J -->|Yes| K[AC washout]
  J -->|No| H
Management algorithm for traumatic hyphema.

Treatment

First-line

  • Protect the eye with a rigid metal or plastic shield (NOT a patch with pressure)
  • Strict bed rest or limited activity with elevation of the head of bed to 30-45 degrees to promote settling of blood inferiorly and prevent obstruction of the visual axis and trabecular meshwork
  • Avoid NSAIDs and aspirin (rebleed risk); use acetaminophen for pain
  • Topical cycloplegic — cyclopentolate 1% or homatropine 5% twice daily — for comfort and to stabilize iris
  • Topical corticosteroid — prednisolone acetate 1% four times daily — to reduce inflammation
  • Daily ophthalmology follow-up for the first 5-7 days due to rebleed and IOP risk
  • Eye shield at night
  • Hold anticoagulants and antiplatelets if medically safe, in consultation with prescribing clinician

Second-line / adjunct

  • Topical IOP-lowering therapy if pressure elevated — timolol, brimonidine, dorzolamide; avoid prostaglandin analogues acutely (inflammation) and avoid carbonic anhydrase inhibitors in sickle cell patients (worsen sickling)
  • Oral aminocaproic acid 50 mg/kg every 4 hours (max 30 g/day) or oral tranexamic acid — antifibrinolytic agents that reduce rebleed risk; their use varies by institution
  • Surgical evacuation (anterior chamber washout) indicated for: corneal blood staining, total hyphema with IOP >50 for >5 days or >35 for >7 days (sickle: lower thresholds; >25 for >24 hours), or persistent hyphema beyond 9-10 days
  • Hospital admission for children, sickle patients, non-compliant patients, severe trauma, or grade III-IV hyphemas at many centers

Complications

  • Rebleeding (typically days 2-5) — increases risk of every other complication
  • Acutely elevated IOP and secondary glaucoma
  • Corneal blood staining — long-term reduction of vision
  • Optic atrophy from sustained IOP elevation
  • Late-onset glaucoma from angle recession (years later — lifelong monitoring required)
  • Synechiae, cataract, vitreous hemorrhage, retinal injury
  • Sickle cell-related profound vision loss from disproportionate IOP elevation

PANCE pearls

  • Always screen for sickle cell disease/trait in at-risk patients with hyphema; it dramatically changes management.
  • Head elevation, eye shield, and strict avoidance of aspirin/NSAIDs are the foundation of medical management.
  • Daily exam in the first week is mandatory; rebleed at days 2-5 worsens outcomes.
  • Avoid carbonic anhydrase inhibitors (acetazolamide, dorzolamide) in sickle patients — they worsen sickling in the AC.
  • Defer gonioscopy until 3-4 weeks; check for angle recession and counsel on lifelong glaucoma surveillance.
  • An '8-ball' total hyphema with high IOP is a surgical emergency.

References

  • AAO PPP — American Academy of Ophthalmology Preferred Practice Pattern: Eye Trauma (relevant sections on hyphema)
  • Cochrane — Cochrane Review: Interventions for traumatic hyphema (Gharaibeh et al., Cochrane Database Syst Rev 2019)
  • AAO BCSC — American Academy of Ophthalmology Basic and Clinical Science Course: Glaucoma and Trauma sections

Practice EENT questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.